"
Team:HKUST-Hong Kong/Achievement
From 2012.igem.org
(Difference between revisions)
Feisun0718 (Talk | contribs) |
|||
| Line 370: | Line 370: | ||
<li>Successfully constructed two parts for BMP2 synthesis and excretion using signaling peptides YbdN and YdjM respectively (<a href="http://partsregistry.org/Part:BBa_K733016" target="_blank">BBa_K733016</a>, <a href="http://partsregistry.org/Part:BBa_K733017" target="_blank">BBa_K733017</a>).</li> | <li>Successfully constructed two parts for BMP2 synthesis and excretion using signaling peptides YbdN and YdjM respectively (<a href="http://partsregistry.org/Part:BBa_K733016" target="_blank">BBa_K733016</a>, <a href="http://partsregistry.org/Part:BBa_K733017" target="_blank">BBa_K733017</a>).</li> | ||
<li>Successfully constructed a cell growth inhibition device for regulating BMP2 production (<a href="http://partsregistry.org/Part:BBa_K733012" target="_blank">BBa_K733012</a>).</li> | <li>Successfully constructed a cell growth inhibition device for regulating BMP2 production (<a href="http://partsregistry.org/Part:BBa_K733012" target="_blank">BBa_K733012</a>).</li> | ||
| - | <li>Successfully characterized the low efficiency promoter Ptms which was used to drive the expression of antitoxin YdcD (<a href="http://partsregistry.org/Part:BBa_K733009" target="_blank">BBa_K733009</a>, <a href="http://partsregistry.org/Part:BBa_K733018" target="_blank">BBa_K733018</a>).</li> | + | <li>Successfully characterized the low efficiency promoter <i>Ptms</i> which was used to drive the expression of antitoxin YdcD (<a href="http://partsregistry.org/Part:BBa_K733009" target="_blank">BBa_K733009</a>, <a href="http://partsregistry.org/Part:BBa_K733018" target="_blank">BBa_K733018</a>).</li> |
<li>Successfully characterized a xylose-inducible promoter that was used to control the expression of BMP2 and toxin YdcE.</li> | <li>Successfully characterized a xylose-inducible promoter that was used to control the expression of BMP2 and toxin YdcE.</li> | ||
<li>Successfully characterized the cell growth inhibition device.</li> | <li>Successfully characterized the cell growth inhibition device.</li> | ||
| Line 489: | Line 489: | ||
</body> | </body> | ||
</html> | </html> | ||
| + | div class="Sitemap_Content"> | ||
Revision as of 21:10, 26 September 2012
Achievement
Our iGEM journey has spanned the length of six months; from the day our project was first proposed in mid-March to the day we ended wet lab work in mid-September.
We are proud to say that within our three months of wet lab work we have achieved the following:
- Successfully constructed the parts for displaying recognition peptide, RPMrel, on the cell wall of Bacillus subtilis (BBa_K733007).
- Successfully constructed two parts for BMP2 synthesis and excretion using signaling peptides YbdN and YdjM respectively (BBa_K733016, BBa_K733017).
- Successfully constructed a cell growth inhibition device for regulating BMP2 production (BBa_K733012).
- Successfully characterized the low efficiency promoter Ptms which was used to drive the expression of antitoxin YdcD (BBa_K733009, BBa_K733018).
- Successfully characterized a xylose-inducible promoter that was used to control the expression of BMP2 and toxin YdcE.
- Successfully characterized the cell growth inhibition device.
Project
Wet Lab
Human Practice
